Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study
The Lancet Regional Health - Europe（2023）
摘要
This study is funded by Daiichi Sankyo Europe GmbH, Munich, Germany.
更多查看译文
关键词
Cardiovascular disease,Cohort study,High cardiovascular risk,LDL cholesterol,Lipid-lowering therapy,Real-world evidence
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要